The development of a successful gene therapy has many stages, including preclinical testing in animal models and proof of principle clinical studies. A variety of diseases affect the lung, which are candidates for gene therapy; this review will mainly focus on the diseases that have attracted the most attention and have therefore yielded the most progress, namely lung cancer and the monogenic disorder cystic fibrosis. Knowledge gained from clinical studies could eventually be applied to more complex lung conditions such as acute respiratory distress syndrome and asthma. In addition, increased gene transfer efficiencies could be obtained by appropriate selection of the gene transfer vector and mode of delivery
Gene therapy for the treatment of cystic fibrosis should be a “natural”: Cystic fibrosis (CF) is a r...
Since the cloning of the cystic fibrosis gene (CFTR) in 1989, 18 clinical trials have been carried o...
The initial concept of human gene therapy was permanent cor-rection of a recessive disease by transp...
Gene therapy, the treatment of any disorder or pathophys-iologic state on the basis of the transfer ...
Gene therapy has not yet met the high expectations of “the early days. ” However, it is a promising ...
consuming and may affect quality of life. New treatments for the pulmonary disease are under clinica...
Advances in DNA- and RNA-based technologies have made gene therapy suitable for many lung diseases, ...
Cystic fibrosis (CF) was one of the first inherited disorders for which gene therapy was seriously c...
Idiopathic pulmonary fibrosis (IPF) is a chronic disease in which the lungs become irreversibly scar...
Improvements in biological research and the development of new techniques for human health protectio...
Gene therapy for pulmonary disease, a field still in the experimental stage, has nonetheless progres...
Abstract The identification of the cystic fibrosis (CF) gene opened the way for gene therapy. In the...
AbstractGene therapy has been considered as the most ideal medical intervention for genetic diseases...
Gene therapy is being developed as a novel treatment for cystic fibrosis (CF), a condition that has ...
The UK Respiratory Gene Therapy Consortium (GTC) The GTC was formed in 2001 from three groups at the...
Gene therapy for the treatment of cystic fibrosis should be a “natural”: Cystic fibrosis (CF) is a r...
Since the cloning of the cystic fibrosis gene (CFTR) in 1989, 18 clinical trials have been carried o...
The initial concept of human gene therapy was permanent cor-rection of a recessive disease by transp...
Gene therapy, the treatment of any disorder or pathophys-iologic state on the basis of the transfer ...
Gene therapy has not yet met the high expectations of “the early days. ” However, it is a promising ...
consuming and may affect quality of life. New treatments for the pulmonary disease are under clinica...
Advances in DNA- and RNA-based technologies have made gene therapy suitable for many lung diseases, ...
Cystic fibrosis (CF) was one of the first inherited disorders for which gene therapy was seriously c...
Idiopathic pulmonary fibrosis (IPF) is a chronic disease in which the lungs become irreversibly scar...
Improvements in biological research and the development of new techniques for human health protectio...
Gene therapy for pulmonary disease, a field still in the experimental stage, has nonetheless progres...
Abstract The identification of the cystic fibrosis (CF) gene opened the way for gene therapy. In the...
AbstractGene therapy has been considered as the most ideal medical intervention for genetic diseases...
Gene therapy is being developed as a novel treatment for cystic fibrosis (CF), a condition that has ...
The UK Respiratory Gene Therapy Consortium (GTC) The GTC was formed in 2001 from three groups at the...
Gene therapy for the treatment of cystic fibrosis should be a “natural”: Cystic fibrosis (CF) is a r...
Since the cloning of the cystic fibrosis gene (CFTR) in 1989, 18 clinical trials have been carried o...
The initial concept of human gene therapy was permanent cor-rection of a recessive disease by transp...